arrow
A

Annika Nelde

eberhard karls university hospital
H指数:27
被引数:2,758

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Personalised multipeptide-based T-cell activator for chronic lymphocytic leukaemia: an open-label, single-centre, phase 1 study

针对慢性淋巴细胞白血病的个性化多肽基T细胞激活剂:一项开放标签、单中心、1期研究

2026-01-140
OAAI
PCI-DB: a novel primary tissue immunopeptidome database to guide next-generation peptide-based immunotherapy development

PCI-DB:一个用于指导下一代肽基免疫疗法开发的新型原发性组织免疫肽组数据库

2025-04-150
OA
Unveiling conserved HIV-1 open reading frames encoding T cell antigens using ribosome profiling (vol 16, 1707, 2025)

揭示编码T细胞抗原的保守HIV-1开放阅读框:利用核糖体定位技术(vol 16, 1707, 2025)

2025-03-060
OA
Unveiling conserved HIV-1 open reading frames encoding T cell antigens using ribosome profiling

揭示编码T细胞抗原的保守HIV-1开放阅读框,使用核糖体定位技术

2025-02-183
OA
Warehouse-based, immunopeptidome-guided design of personalised peptide vaccines shows feasibility in clinical trial evaluation in CLL patients
2024-11-260
OAAI
FLT3-ITD Driven CMTM6 Expression Contributes to Immune Escape of Acute Myeloid Leukemia

FLT3-ITD 驱动的 CMTM6 表达促进了急性髓系白血病的免疫逃逸。

BLOOD
IF23.1
2024-11-050
PRE
AML-VAC-XS15-01: protocol of a first-in-human clinical trial to evaluate the safety, tolerability and preliminary efficacy of a multi-peptide vaccine based on leukemia stem cell antigens in acute myeloid leukemia patients
2024-10-140
OAAI
Phase I trial of a personalized multi-peptide vaccine combined with the TLR1/2 ligand XS15 under Bruton-Tyrosine-Kinase inhibitor (BTKi) treatment in chronic lymphocytic leukemia (CLL) patients

一期临床试验:在慢性淋巴细胞白血病(CLL)患者中,接受Bruton-Tyrosine-Kinase抑制剂(BTKi)治疗期间,个性化多肽疫苗与TLR1/2配体XS15联合应用。

2024-09-010
PRE
FusionVAC22_01: a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusion
2024-03-283
OAAI
TOFIMS mass spectrometry-based immunopeptidomics refines tumor antigen identification

基于TOFIMS质谱的免疫抗体优化肿瘤抗原鉴定

2023-11-177
OAAI
Immune Surveillance of Acute Myeloid Leukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells

急性髓系白血病的免疫监视是由白血病祖细胞上的HLA呈递抗原介导的

2023-10-179
OAAI
Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency
2023-08-1812
OAAI